Iopidine

Apraclonidine, the active ingredient in Iopidine, is an alpha-2 adrenergic agonist presented as an ophthalmic solution for ocular administration. It selectively stimulates alpha-2 receptors in the eye, decreasing aqueous humor production and enhancing uveoscleral outflow, thereby lowering intra‑ocular pressure in patients with ocular hypertension, open‑angle glaucoma, and postoperative ocular inflammation. The medication is indicated for short‑term control of intra‑ocular pressure and is typically prescribed by ophthalmologists as part of a comprehensive glaucoma management plan.

GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Apraclonidine is used to manage ocular conditions characterized by elevated intra‑ocular pressure. - Ocular hypertension: lowers intra‑ocular pressure to reduce the risk of progression to glaucoma. - Open-angle glaucoma: decreases aqueous humor production to control pressure and preserve visual field. - Post‑operative ocular inflammation: reduces pressure spikes after eye surgery, aiding recovery. - Secondary glaucoma: provides additional pressure reduction when first‑line agents are inadequate.

Common Side Effects: - Ocular burning or stinging sensation. - Redness of the eye. - Blurred vision. - Dry eye sensation. - Transient headache. - Mild conjunctival hyperemia.

Serious or Rare Side Effects: - Allergic reaction with swelling or rash. - Severe eye pain or corneal edema. - Systemic hypotension. - Arrhythmia or cardiac rhythm disturbances. - Vision loss. - Persistent ocular inflammation.

Before using Iopidine, consider the following precautions: - Monitor intra‑ocular pressure: measure regularly after initiation. - Avoid use in patients with known hypersensitivity to apraclonidine or any formulation component. - Caution in patients with cardiovascular disease: monitor blood pressure and heart rate. - Use with care when combined with other ocular hypotensive agents to prevent excessive pressure reduction. - Store at room temperature: keep in the original container, protect from light and moisture.

Apraclonidine may interact with other medicines as follows:

Major Interactions (Avoid): - Other ocular alpha‑2 agonists: may cause excessive intra‑ocular pressure reduction. - Systemic antihypertensives: may potentiate systemic hypotension. - Monoamine oxidase inhibitors: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Topical beta‑blockers: additive intra‑ocular pressure‑lowering effect. - Carbonic anhydrase inhibitors: enhanced ocular hypotensive effect. - NSAID eye drops: may increase ocular irritation.